A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST)

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG

Sunitinib malate (SU011248)

SU011248

Trial Locations (4)

Pfizer Investigational Site, Kashiwa

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Suita

Pfizer Investigational Site, Chuo-ku